Physician profile
Michael D Seidner
NPI 1891746145
$3,572.70
in general payments reported to CMS, 2019-2025
12 companies · $21.66 in 2025
The $21.66 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,225 · 2020: $1,386 · 2021: $662 · 2022: $140 · 2023: $120 · 2024: $17.96 · 2025: $21.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $2,165.00 | 2019-2020 | |
| Medtronic, INC. | $650.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $227.27 | 2019-2022 | |
| Astellas Pharma US INC | $141.95 | 2023-2025 | Veozah |
| Abbvie INC. | $126.96 | 2019-2022 | |
| Innovation Technologies INC | $105.67 | 2020 | |
| Exeltis, USA INC. | $61.73 | 2019-2024 | Slynd |
| Avion Pharmaceuticals | $35.76 | 2019-2021 | |
| Roche Diagnostics Corporation | $19.56 | 2020 | |
| Lupin INC. | $14.82 | 2019 | |
| Allergan, INC. | $12.81 | 2019 | |
| Amarin Pharma, INC. | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Seidner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.